Business Description
Cardiovascular Systems Inc
NAICS : 339112
SIC : 3841
Description
Cardiovascular Systems Inc is a medical technology company focused on patients with peripheral and coronary artery diseases. Its peripheral artery disease systems are catheter-based platforms used to treat plaque in leg arteries above and below the knee. The firm's orbital atherectomy systems are used in peripheral and coronary commercial applications. Its OAS products include the Diamondback 360 Peripheral and Stealth 360 systems. Sales of Peripheral OAS contribute the majority of revenue. Cardiovascular systems generate the vast majority of its revenue in the United States.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.71 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | -0.67 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 3.97 | |||||
| Beneish M-Score | -2.37 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -6.6 | |||||
| 3-Year EPS without NRI Growth Rate | -354.7 | |||||
| 3-Year Book Growth Rate | 12.9 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 2.64 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.05 | |||||
| 9-Day RSI | 38.1 | |||||
| 14-Day RSI | 42.1 | |||||
| 6-1 Month Momentum % | -7.9 | |||||
| 12-1 Month Momentum % | -29.84 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.22 | |||||
| Quick Ratio | 5.2 | |||||
| Cash Ratio | 3.87 | |||||
| Days Inventory | 188.7 | |||||
| Days Sales Outstanding | 57.16 | |||||
| Days Payable | 77.78 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.5 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 72.29 | |||||
| Operating Margin % | -16.25 | |||||
| Net Margin % | -16.4 | |||||
| ROE % | -15.36 | |||||
| ROA % | -12.04 | |||||
| ROIC % | -33.41 | |||||
| ROC (Joel Greenblatt) % | -55.28 | |||||
| ROCE % | -13.19 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.35 | |||||
| PB Ratio | 2.42 | |||||
| Price-to-Tangible-Book | 2.59 | |||||
| EV-to-EBIT | -11.79 | |||||
| EV-to-EBITDA | -13.62 | |||||
| EV-to-Revenue | 1.84 | |||||
| EV-to-Forward-Revenue | 1.68 | |||||
| EV-to-FCF | -14.16 | |||||
| Price-to-Projected-FCF | 3.89 | |||||
| Price-to-Median-PS-Value | 0.49 | |||||
| Price-to-Net-Current-Asset-Value | 3.64 | |||||
| Price-to-Net-Cash | 7.96 | |||||
| Earnings Yield (Greenblatt) % | -8.48 |
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CSII
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Executives
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 237.525 | ||
| EPS (TTM) ($) | -1 | ||
| Beta | 0.75 | ||
| Volatility % | 56.16 | ||
| 14-Day RSI | 42.1 | ||
| 14-Day ATR ($) | 0.780106 | ||
| 20-Day SMA ($) | 14.1835 | ||
| 12-1 Month Momentum % | -29.84 | ||
| 52-Week Range ($) | 12.255 - 23.47 | ||
| Shares Outstanding (Mil) | 41.88 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cardiovascular Systems Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cardiovascular Systems Inc Analysis
Share your researchHeadlines
See More
No news.